The largest database of trusted experimental protocols

Vegfr2 55b11

Manufactured by Cell Signaling Technology
Sourced in United Kingdom, Germany, United States, Czechia

VEGFR2 (55B11) is a laboratory reagent produced by Cell Signaling Technology. It is an antibody that specifically binds to the vascular endothelial growth factor receptor 2 (VEGFR2) protein. VEGFR2 is a receptor tyrosine kinase that plays a key role in angiogenesis and vascular development.

Automatically generated - may contain errors

7 protocols using vegfr2 55b11

1

Cytospin Preparation and Immunostaining of Colorectal Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cytospin preparations, HT29 or Caco-2 colorectal cancer cells were harvested using Accutase (Sigma-Aldrich, Munich, Germany) and adjusted to a final concentration of 2 × 105 cells/ml. Cytospin preparations were performed with 50 μl of cell suspension at 550 rpm for one minute in a Cytospin4 cytocentrifuge (Thermo Fisher Scientific) and incubated with the following antibodies: PDGFRα (D1E1E) (Cell Signaling Technology) at a dilution of 1:500; PDGFRβ (28E1) (Cell Signaling Technology) at a dilution of 1:100; VEGFR1 (Y103) (Abcam, Cambridge, UK) at a dilution of 1:250; VEGFR2 (55B11) (Cell Signaling Technology) at a dilution of 1:200.
+ Open protocol
+ Expand
2

Immunoprecipitation of Cadherins and VEGFR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Confluent HUVECs in complete medium were rinsed with PBS containing 1 mM Ca2+ and 0.5 mM Mg2+, then lysed with cold 25 mM Tris, pH 7.5, 600 mM NaCl, 0.3% CHAPS (3023; Sigma-Aldrich), 0.15% Triton X-100, 1.5× PhosSTOP (Roche), and 1.5× Protease inhibitor (Roche) at 1 ml/106 cells. Lysates were drawn through a 23G syringe 15 times and incubated on ice for 30 min before clarification at 20,000 g for 10 min. Clarified lysates were immunoprecipitated with either anti-Flag resin (Sigma-Aldrich) or Protein A/G beads (Santa Cruz Biotechnology, Inc.) bound to anti-cadherin (VEcad, BV9 [Santa Cruz Biotechnology, Inc.]; Ncad, 610920 [BD]) or VEGFR (VEGFR2, 55B11 [Cell Signaling Technologies]; VEGFR3, AF349 [R&D Systems]) antibodies, as indicated, for 2.5 h at 4°C. Beads were washed three times with 1 ml of lysis buffer. Flag immunoprecipitates were eluted at 4°C for 60 min in lysis buffer with 0.2 mg/ml 3×-flag peptide (Sigma-Aldrich). Eluted proteins were then collected in protein sample buffer (PSB), then analyzed by SDS-PAGE and immunoblotting with chemiluminescent HRP detection.
+ Open protocol
+ Expand
3

Western Blot Analysis of VEGFR2 and ASM

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed with NP-40 buffer containing protease and phosphatase inhibitors (Sigma-Aldrich). Lysates were centrifuged at 13,400 rpm at 4 °C and the supernatant was collected. Equal amounts of protein were separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) and subsequently transferred to nitrocellulose membranes (GE Healthcare Life Science). Non-specific binding was blocked with 5% non-fat milk powder (Sigma-Aldrich) dissolved in 0.1% Tween in 0.1 M Tris-buffered saline (TBS-T). Membranes were incubated with rabbit anti-vascular endothelial growth factor (VEGF) receptor-2 (VEGFR2) (55B11; Cell Signaling Technology), goat anti-ASM (AF5348, R&D Systems) and rabbit anti-β-actin (4967; Cell Signaling Technology) antibody overnight at 4 °C, rinsed and incubated in peroxidase-conjugated secondary antibodies (Santa Cruz, Heidelberg, Germany) for 1 h at room temperature. Signals were detected by enhanced chemiluminescence using prime Western blotting detection reagent (GE Healthcare Life Science). VEGFR2 and ASM expression were normalized to β-actin abundance.
+ Open protocol
+ Expand
4

VEGF-A Regulation of EZH2 and HIF-1α

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells lines were serum-starved for 24 hours and stimulated in fresh medium with 50 ng/mL VEGF-A (Cell Signaling Technology). Cells were then incubated under normoxic conditions, and protein lysates were collected 18 hours later. Western blot analysis was carried out using specific antibodies against EZH2 (AC22), H3K27me3 (C36B11), HIF-1α (HIF-1α antibody), VEGFR-2 (55B11) (Cell Signaling Technology), and E2F3 (ab54945; Abcam).
+ Open protocol
+ Expand
5

Immunofluorescence Staining of HUVECs and rMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs and rMCs were cultured according to experimental conditions and subsequently washed with PBS and fixed with 4% Histofix for 10 min, after which they were incubated with a permeabilization/blocking solution (2.5% BSA and 0.3% Triton-X in PBS) for 1 h at room temperature. The cells were further incubated with 200 μL of primary antibody solution (VEGFR2 55B11, Cell Signaling; Ang2 SC74403, Santa Cruz; GFAP Z0334, Dako; diluted 1:200 in PBS) overnight at 4 °C, then washed thrice with PBS and incubated with the secondary antibodies (swine anti-rabbit FITC, F0205, Dako; diluted 1:20 in PBS) for 1 h at room temperature in the dark. The cells were subsequently washed thrice with PBS, incubated with DAPI (1 μg/mL) for 10 min, and washed twice with PBS. They then were covered with Roti FluorCare mounting medium and covered with coverslips. The images were obtained using a Leica SP8 confocal microscope, and fluorescence intensity quantification was done using ImageJ.
+ Open protocol
+ Expand
6

Antibody Panel for Angiogenesis Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies against VE-cadherin (#2158), phospho-VEGFR2 at Tyr1175 (D5B11, #3770), VEGFR2 (55B11, #2479), phospho-AKT at Ser473 (D9E, #4060), AKT (C67E7, #4691), phospho-ERK1/2 (p44/42 MAPK, 137F5, #4695), GAPDH (D16H11, #5174) and pan-Actin (D18C11, #8456) were from Cell Signalling Technology (CST; Danvers, MA, USA). The antibody anti-RCAN1 (#D6694) was from Sigma-Aldrich (St. Louis, MO, USA), anti-CD81 (MCA1847) was from BioRad (Hercules, CA, USA), anti-CD9 (#10626D) was from ThermoFisher (Waltham, MA, USA), anti-CD63 (#556019) was from BDBiosciences (Franklin Lakes, NJ, USA), and anti-GRP78 was from Serotec (Raleigh, NC, USA). Secondary anti-rabbit or anti-mouse Horseradish Peroxidase (HRP)-coupled antibodies were from Jackson Immunoresearch (West Grove, PA, USA) and anti-rabbit Alexa488 antibody (#A-21206) was from Invitrogen (Waltham, MA, USA).
Human recombinant VEGFA165 was obtained from Proteintech (#HZ-1038; Rosemont, IL, USA).
+ Open protocol
+ Expand
7

Shedding Light on Angiogenic Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed with NP-40 buffer containing protease and phosphatase inhibitors (Sigma-Aldrich). Lysates were centrifuged at 13,400 rpm at 4°C and the supernatant was collected. Equal amounts of protein were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and subsequently transferred to nitrocellulose membranes (GE Healthcare Life Science). Non-specific binding was blocked with 5% non-fat milk powder (Sigma-Aldrich) dissolved in 0.1% Tween in 0.1 M Tris-buffered saline (TBS-T). Membranes were incubated with rabbit anti-vascular endothelial growth factor (VEGF) receptor-2 (VEGFR2) (55B11; Cell Signaling Technology), goat anti-ASM (AF5348, R&D Systems) and rabbit anti-β-actin (4967; Acid sphingomyelinase deactivation post-ischemia/ reperfusion promotes angiogenesis/ 26 Amnis ImagestreamX flow cytometry of sEVs sEVs were quantified with an ImageStreamX MkII instrument (Merck Millipore) as described previously 55 after CD9-FITC (MEM-61; Exbio, Vestec, Czech Republic) and CD63-APC (MEM-259; Exbio) antibody staining. All samples were appropriately diluted in order to avoid coincidence or swarm detection. Data analysis was performed using Amnis IDEAS software (version 6.1).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!